18F-FDG PET, the early phases and the delivery rate of 18F-AV45 PET as proxies of cerebral blood flow in Alzheimer's disease: Validation against 15O-H2O PET
Dual-biomarker positron emission tomography (PET), providing complementary information on cerebral blood flow and amyloid-β deposition, is of clinical interest for Alzheimer's disease (AD). The purpose of this study was to validate the perfusion components of early-phase 18F-florbetapir (eAV45)...
Ausführliche Beschreibung
Gespeichert in:
| Autor*in: |
Ottoy, Julie [verfasserIn] |
|---|
| Format: |
E-Artikel |
|---|---|
| Sprache: |
Englisch |
| Erschienen: |
2019 |
|---|
| Schlagwörter: |
|---|
| Umfang: |
11 |
|---|
| Übergeordnetes Werk: |
Enthalten in: Multi-objective optimization of the solar absorptivity distribution inside a cavity solar receiver for solar power towers - Wang, Kun ELSEVIER, 2017, the journal of the Alzheimer's Association, Amsterdam [u.a.] |
|---|---|
| Übergeordnetes Werk: |
volume:15 ; year:2019 ; number:9 ; pages:1172-1182 ; extent:11 |
| Links: |
|---|
| DOI / URN: |
10.1016/j.jalz.2019.05.010 |
|---|
| Katalog-ID: |
ELV047979240 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | ELV047979240 | ||
| 003 | DE-627 | ||
| 005 | 20230624142225.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 191023s2019 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.jalz.2019.05.010 |2 doi | |
| 028 | 5 | 2 | |a /cbs_pica/cbs_olc/import_discovery/elsevier/einzuspielen/GBV00000000001216.pica |
| 035 | |a (DE-627)ELV047979240 | ||
| 035 | |a (ELSEVIER)S1552-5260(19)30151-7 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 082 | 0 | 4 | |a 530 |q VZ |
| 084 | |a 52.56 |2 bkl | ||
| 100 | 1 | |a Ottoy, Julie |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a 18F-FDG PET, the early phases and the delivery rate of 18F-AV45 PET as proxies of cerebral blood flow in Alzheimer's disease: Validation against 15O-H2O PET |
| 264 | 1 | |c 2019 | |
| 300 | |a 11 | ||
| 336 | |a nicht spezifiziert |b zzz |2 rdacontent | ||
| 337 | |a nicht spezifiziert |b z |2 rdamedia | ||
| 338 | |a nicht spezifiziert |b zu |2 rdacarrier | ||
| 520 | |a Dual-biomarker positron emission tomography (PET), providing complementary information on cerebral blood flow and amyloid-β deposition, is of clinical interest for Alzheimer's disease (AD). The purpose of this study was to validate the perfusion components of early-phase 18F-florbetapir (eAV45), the 18F-AV45 delivery rate (R1), and 18F-FDG against 15O-H2O PET and assess how they change with disease severity. | ||
| 650 | 7 | |a Perfusion imaging |2 Elsevier | |
| 650 | 7 | |a Cerebral blood flow |2 Elsevier | |
| 650 | 7 | |a 18F-FDG |2 Elsevier | |
| 650 | 7 | |a Dual-phase PET |2 Elsevier | |
| 650 | 7 | |a Early-phase PET |2 Elsevier | |
| 650 | 7 | |a Alzheimer's disease |2 Elsevier | |
| 650 | 7 | |a 15O-H2O |2 Elsevier | |
| 650 | 7 | |a 18F-AV45 |2 Elsevier | |
| 650 | 7 | |a R1 |2 Elsevier | |
| 700 | 1 | |a Verhaeghe, Jeroen |4 oth | |
| 700 | 1 | |a Niemantsverdriet, Ellis |4 oth | |
| 700 | 1 | |a De Roeck, Ellen |4 oth | |
| 700 | 1 | |a wyffels, Leonie |4 oth | |
| 700 | 1 | |a Ceyssens, Sarah |4 oth | |
| 700 | 1 | |a Van Broeckhoven, Christine |4 oth | |
| 700 | 1 | |a Engelborghs, Sebastiaan |4 oth | |
| 700 | 1 | |a Stroobants, Sigrid |4 oth | |
| 700 | 1 | |a Staelens, Steven |4 oth | |
| 773 | 0 | 8 | |i Enthalten in |n Elsevier |a Wang, Kun ELSEVIER |t Multi-objective optimization of the solar absorptivity distribution inside a cavity solar receiver for solar power towers |d 2017 |d the journal of the Alzheimer's Association |g Amsterdam [u.a.] |w (DE-627)ELV000066591 |
| 773 | 1 | 8 | |g volume:15 |g year:2019 |g number:9 |g pages:1172-1182 |g extent:11 |
| 856 | 4 | 0 | |u https://doi.org/10.1016/j.jalz.2019.05.010 |3 Volltext |
| 912 | |a GBV_USEFLAG_U | ||
| 912 | |a GBV_ELV | ||
| 912 | |a SYSFLAG_U | ||
| 936 | b | k | |a 52.56 |j Regenerative Energieformen |j alternative Energieformen |q VZ |
| 951 | |a AR | ||
| 952 | |d 15 |j 2019 |e 9 |h 1172-1182 |g 11 | ||
| author_variant |
j o jo |
|---|---|
| matchkey_str |
ottoyjulieverhaeghejeroenniemantsverdrie:2019----:8fgetealpaeadhdlvrrto1fv5eapoisfeerllofoiazemr |
| hierarchy_sort_str |
2019 |
| bklnumber |
52.56 |
| publishDate |
2019 |
| allfields |
10.1016/j.jalz.2019.05.010 doi /cbs_pica/cbs_olc/import_discovery/elsevier/einzuspielen/GBV00000000001216.pica (DE-627)ELV047979240 (ELSEVIER)S1552-5260(19)30151-7 DE-627 ger DE-627 rakwb eng 530 VZ 52.56 bkl Ottoy, Julie verfasserin aut 18F-FDG PET, the early phases and the delivery rate of 18F-AV45 PET as proxies of cerebral blood flow in Alzheimer's disease: Validation against 15O-H2O PET 2019 11 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Dual-biomarker positron emission tomography (PET), providing complementary information on cerebral blood flow and amyloid-β deposition, is of clinical interest for Alzheimer's disease (AD). The purpose of this study was to validate the perfusion components of early-phase 18F-florbetapir (eAV45), the 18F-AV45 delivery rate (R1), and 18F-FDG against 15O-H2O PET and assess how they change with disease severity. Perfusion imaging Elsevier Cerebral blood flow Elsevier 18F-FDG Elsevier Dual-phase PET Elsevier Early-phase PET Elsevier Alzheimer's disease Elsevier 15O-H2O Elsevier 18F-AV45 Elsevier R1 Elsevier Verhaeghe, Jeroen oth Niemantsverdriet, Ellis oth De Roeck, Ellen oth wyffels, Leonie oth Ceyssens, Sarah oth Van Broeckhoven, Christine oth Engelborghs, Sebastiaan oth Stroobants, Sigrid oth Staelens, Steven oth Enthalten in Elsevier Wang, Kun ELSEVIER Multi-objective optimization of the solar absorptivity distribution inside a cavity solar receiver for solar power towers 2017 the journal of the Alzheimer's Association Amsterdam [u.a.] (DE-627)ELV000066591 volume:15 year:2019 number:9 pages:1172-1182 extent:11 https://doi.org/10.1016/j.jalz.2019.05.010 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U 52.56 Regenerative Energieformen alternative Energieformen VZ AR 15 2019 9 1172-1182 11 |
| spelling |
10.1016/j.jalz.2019.05.010 doi /cbs_pica/cbs_olc/import_discovery/elsevier/einzuspielen/GBV00000000001216.pica (DE-627)ELV047979240 (ELSEVIER)S1552-5260(19)30151-7 DE-627 ger DE-627 rakwb eng 530 VZ 52.56 bkl Ottoy, Julie verfasserin aut 18F-FDG PET, the early phases and the delivery rate of 18F-AV45 PET as proxies of cerebral blood flow in Alzheimer's disease: Validation against 15O-H2O PET 2019 11 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Dual-biomarker positron emission tomography (PET), providing complementary information on cerebral blood flow and amyloid-β deposition, is of clinical interest for Alzheimer's disease (AD). The purpose of this study was to validate the perfusion components of early-phase 18F-florbetapir (eAV45), the 18F-AV45 delivery rate (R1), and 18F-FDG against 15O-H2O PET and assess how they change with disease severity. Perfusion imaging Elsevier Cerebral blood flow Elsevier 18F-FDG Elsevier Dual-phase PET Elsevier Early-phase PET Elsevier Alzheimer's disease Elsevier 15O-H2O Elsevier 18F-AV45 Elsevier R1 Elsevier Verhaeghe, Jeroen oth Niemantsverdriet, Ellis oth De Roeck, Ellen oth wyffels, Leonie oth Ceyssens, Sarah oth Van Broeckhoven, Christine oth Engelborghs, Sebastiaan oth Stroobants, Sigrid oth Staelens, Steven oth Enthalten in Elsevier Wang, Kun ELSEVIER Multi-objective optimization of the solar absorptivity distribution inside a cavity solar receiver for solar power towers 2017 the journal of the Alzheimer's Association Amsterdam [u.a.] (DE-627)ELV000066591 volume:15 year:2019 number:9 pages:1172-1182 extent:11 https://doi.org/10.1016/j.jalz.2019.05.010 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U 52.56 Regenerative Energieformen alternative Energieformen VZ AR 15 2019 9 1172-1182 11 |
| allfields_unstemmed |
10.1016/j.jalz.2019.05.010 doi /cbs_pica/cbs_olc/import_discovery/elsevier/einzuspielen/GBV00000000001216.pica (DE-627)ELV047979240 (ELSEVIER)S1552-5260(19)30151-7 DE-627 ger DE-627 rakwb eng 530 VZ 52.56 bkl Ottoy, Julie verfasserin aut 18F-FDG PET, the early phases and the delivery rate of 18F-AV45 PET as proxies of cerebral blood flow in Alzheimer's disease: Validation against 15O-H2O PET 2019 11 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Dual-biomarker positron emission tomography (PET), providing complementary information on cerebral blood flow and amyloid-β deposition, is of clinical interest for Alzheimer's disease (AD). The purpose of this study was to validate the perfusion components of early-phase 18F-florbetapir (eAV45), the 18F-AV45 delivery rate (R1), and 18F-FDG against 15O-H2O PET and assess how they change with disease severity. Perfusion imaging Elsevier Cerebral blood flow Elsevier 18F-FDG Elsevier Dual-phase PET Elsevier Early-phase PET Elsevier Alzheimer's disease Elsevier 15O-H2O Elsevier 18F-AV45 Elsevier R1 Elsevier Verhaeghe, Jeroen oth Niemantsverdriet, Ellis oth De Roeck, Ellen oth wyffels, Leonie oth Ceyssens, Sarah oth Van Broeckhoven, Christine oth Engelborghs, Sebastiaan oth Stroobants, Sigrid oth Staelens, Steven oth Enthalten in Elsevier Wang, Kun ELSEVIER Multi-objective optimization of the solar absorptivity distribution inside a cavity solar receiver for solar power towers 2017 the journal of the Alzheimer's Association Amsterdam [u.a.] (DE-627)ELV000066591 volume:15 year:2019 number:9 pages:1172-1182 extent:11 https://doi.org/10.1016/j.jalz.2019.05.010 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U 52.56 Regenerative Energieformen alternative Energieformen VZ AR 15 2019 9 1172-1182 11 |
| allfieldsGer |
10.1016/j.jalz.2019.05.010 doi /cbs_pica/cbs_olc/import_discovery/elsevier/einzuspielen/GBV00000000001216.pica (DE-627)ELV047979240 (ELSEVIER)S1552-5260(19)30151-7 DE-627 ger DE-627 rakwb eng 530 VZ 52.56 bkl Ottoy, Julie verfasserin aut 18F-FDG PET, the early phases and the delivery rate of 18F-AV45 PET as proxies of cerebral blood flow in Alzheimer's disease: Validation against 15O-H2O PET 2019 11 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Dual-biomarker positron emission tomography (PET), providing complementary information on cerebral blood flow and amyloid-β deposition, is of clinical interest for Alzheimer's disease (AD). The purpose of this study was to validate the perfusion components of early-phase 18F-florbetapir (eAV45), the 18F-AV45 delivery rate (R1), and 18F-FDG against 15O-H2O PET and assess how they change with disease severity. Perfusion imaging Elsevier Cerebral blood flow Elsevier 18F-FDG Elsevier Dual-phase PET Elsevier Early-phase PET Elsevier Alzheimer's disease Elsevier 15O-H2O Elsevier 18F-AV45 Elsevier R1 Elsevier Verhaeghe, Jeroen oth Niemantsverdriet, Ellis oth De Roeck, Ellen oth wyffels, Leonie oth Ceyssens, Sarah oth Van Broeckhoven, Christine oth Engelborghs, Sebastiaan oth Stroobants, Sigrid oth Staelens, Steven oth Enthalten in Elsevier Wang, Kun ELSEVIER Multi-objective optimization of the solar absorptivity distribution inside a cavity solar receiver for solar power towers 2017 the journal of the Alzheimer's Association Amsterdam [u.a.] (DE-627)ELV000066591 volume:15 year:2019 number:9 pages:1172-1182 extent:11 https://doi.org/10.1016/j.jalz.2019.05.010 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U 52.56 Regenerative Energieformen alternative Energieformen VZ AR 15 2019 9 1172-1182 11 |
| allfieldsSound |
10.1016/j.jalz.2019.05.010 doi /cbs_pica/cbs_olc/import_discovery/elsevier/einzuspielen/GBV00000000001216.pica (DE-627)ELV047979240 (ELSEVIER)S1552-5260(19)30151-7 DE-627 ger DE-627 rakwb eng 530 VZ 52.56 bkl Ottoy, Julie verfasserin aut 18F-FDG PET, the early phases and the delivery rate of 18F-AV45 PET as proxies of cerebral blood flow in Alzheimer's disease: Validation against 15O-H2O PET 2019 11 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Dual-biomarker positron emission tomography (PET), providing complementary information on cerebral blood flow and amyloid-β deposition, is of clinical interest for Alzheimer's disease (AD). The purpose of this study was to validate the perfusion components of early-phase 18F-florbetapir (eAV45), the 18F-AV45 delivery rate (R1), and 18F-FDG against 15O-H2O PET and assess how they change with disease severity. Perfusion imaging Elsevier Cerebral blood flow Elsevier 18F-FDG Elsevier Dual-phase PET Elsevier Early-phase PET Elsevier Alzheimer's disease Elsevier 15O-H2O Elsevier 18F-AV45 Elsevier R1 Elsevier Verhaeghe, Jeroen oth Niemantsverdriet, Ellis oth De Roeck, Ellen oth wyffels, Leonie oth Ceyssens, Sarah oth Van Broeckhoven, Christine oth Engelborghs, Sebastiaan oth Stroobants, Sigrid oth Staelens, Steven oth Enthalten in Elsevier Wang, Kun ELSEVIER Multi-objective optimization of the solar absorptivity distribution inside a cavity solar receiver for solar power towers 2017 the journal of the Alzheimer's Association Amsterdam [u.a.] (DE-627)ELV000066591 volume:15 year:2019 number:9 pages:1172-1182 extent:11 https://doi.org/10.1016/j.jalz.2019.05.010 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U 52.56 Regenerative Energieformen alternative Energieformen VZ AR 15 2019 9 1172-1182 11 |
| language |
English |
| source |
Enthalten in Multi-objective optimization of the solar absorptivity distribution inside a cavity solar receiver for solar power towers Amsterdam [u.a.] volume:15 year:2019 number:9 pages:1172-1182 extent:11 |
| sourceStr |
Enthalten in Multi-objective optimization of the solar absorptivity distribution inside a cavity solar receiver for solar power towers Amsterdam [u.a.] volume:15 year:2019 number:9 pages:1172-1182 extent:11 |
| format_phy_str_mv |
Article |
| bklname |
Regenerative Energieformen alternative Energieformen |
| institution |
findex.gbv.de |
| topic_facet |
Perfusion imaging Cerebral blood flow 18F-FDG Dual-phase PET Early-phase PET Alzheimer's disease 15O-H2O 18F-AV45 R1 |
| dewey-raw |
530 |
| isfreeaccess_bool |
false |
| container_title |
Multi-objective optimization of the solar absorptivity distribution inside a cavity solar receiver for solar power towers |
| authorswithroles_txt_mv |
Ottoy, Julie @@aut@@ Verhaeghe, Jeroen @@oth@@ Niemantsverdriet, Ellis @@oth@@ De Roeck, Ellen @@oth@@ wyffels, Leonie @@oth@@ Ceyssens, Sarah @@oth@@ Van Broeckhoven, Christine @@oth@@ Engelborghs, Sebastiaan @@oth@@ Stroobants, Sigrid @@oth@@ Staelens, Steven @@oth@@ |
| publishDateDaySort_date |
2019-01-01T00:00:00Z |
| hierarchy_top_id |
ELV000066591 |
| dewey-sort |
3530 |
| id |
ELV047979240 |
| language_de |
englisch |
| fullrecord |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">ELV047979240</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230624142225.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">191023s2019 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1016/j.jalz.2019.05.010</subfield><subfield code="2">doi</subfield></datafield><datafield tag="028" ind1="5" ind2="2"><subfield code="a">/cbs_pica/cbs_olc/import_discovery/elsevier/einzuspielen/GBV00000000001216.pica</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)ELV047979240</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ELSEVIER)S1552-5260(19)30151-7</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">530</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">52.56</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Ottoy, Julie</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">18F-FDG PET, the early phases and the delivery rate of 18F-AV45 PET as proxies of cerebral blood flow in Alzheimer's disease: Validation against 15O-H2O PET</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2019</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">11</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zzz</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">z</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zu</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Dual-biomarker positron emission tomography (PET), providing complementary information on cerebral blood flow and amyloid-β deposition, is of clinical interest for Alzheimer's disease (AD). The purpose of this study was to validate the perfusion components of early-phase 18F-florbetapir (eAV45), the 18F-AV45 delivery rate (R1), and 18F-FDG against 15O-H2O PET and assess how they change with disease severity.</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Perfusion imaging</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Cerebral blood flow</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">18F-FDG</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Dual-phase PET</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Early-phase PET</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Alzheimer's disease</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">15O-H2O</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">18F-AV45</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">R1</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Verhaeghe, Jeroen</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Niemantsverdriet, Ellis</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">De Roeck, Ellen</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">wyffels, Leonie</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Ceyssens, Sarah</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Van Broeckhoven, Christine</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Engelborghs, Sebastiaan</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Stroobants, Sigrid</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Staelens, Steven</subfield><subfield code="4">oth</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="n">Elsevier</subfield><subfield code="a">Wang, Kun ELSEVIER</subfield><subfield code="t">Multi-objective optimization of the solar absorptivity distribution inside a cavity solar receiver for solar power towers</subfield><subfield code="d">2017</subfield><subfield code="d">the journal of the Alzheimer's Association</subfield><subfield code="g">Amsterdam [u.a.]</subfield><subfield code="w">(DE-627)ELV000066591</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:15</subfield><subfield code="g">year:2019</subfield><subfield code="g">number:9</subfield><subfield code="g">pages:1172-1182</subfield><subfield code="g">extent:11</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1016/j.jalz.2019.05.010</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ELV</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_U</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">52.56</subfield><subfield code="j">Regenerative Energieformen</subfield><subfield code="j">alternative Energieformen</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">15</subfield><subfield code="j">2019</subfield><subfield code="e">9</subfield><subfield code="h">1172-1182</subfield><subfield code="g">11</subfield></datafield></record></collection>
|
| author |
Ottoy, Julie |
| spellingShingle |
Ottoy, Julie ddc 530 bkl 52.56 Elsevier Perfusion imaging Elsevier Cerebral blood flow Elsevier 18F-FDG Elsevier Dual-phase PET Elsevier Early-phase PET Elsevier Alzheimer's disease Elsevier 15O-H2O Elsevier 18F-AV45 Elsevier R1 18F-FDG PET, the early phases and the delivery rate of 18F-AV45 PET as proxies of cerebral blood flow in Alzheimer's disease: Validation against 15O-H2O PET |
| authorStr |
Ottoy, Julie |
| ppnlink_with_tag_str_mv |
@@773@@(DE-627)ELV000066591 |
| format |
electronic Article |
| dewey-ones |
530 - Physics |
| delete_txt_mv |
keep |
| author_role |
aut |
| collection |
elsevier |
| remote_str |
true |
| illustrated |
Not Illustrated |
| topic_title |
530 VZ 52.56 bkl 18F-FDG PET, the early phases and the delivery rate of 18F-AV45 PET as proxies of cerebral blood flow in Alzheimer's disease: Validation against 15O-H2O PET Perfusion imaging Elsevier Cerebral blood flow Elsevier 18F-FDG Elsevier Dual-phase PET Elsevier Early-phase PET Elsevier Alzheimer's disease Elsevier 15O-H2O Elsevier 18F-AV45 Elsevier R1 Elsevier |
| topic |
ddc 530 bkl 52.56 Elsevier Perfusion imaging Elsevier Cerebral blood flow Elsevier 18F-FDG Elsevier Dual-phase PET Elsevier Early-phase PET Elsevier Alzheimer's disease Elsevier 15O-H2O Elsevier 18F-AV45 Elsevier R1 |
| topic_unstemmed |
ddc 530 bkl 52.56 Elsevier Perfusion imaging Elsevier Cerebral blood flow Elsevier 18F-FDG Elsevier Dual-phase PET Elsevier Early-phase PET Elsevier Alzheimer's disease Elsevier 15O-H2O Elsevier 18F-AV45 Elsevier R1 |
| topic_browse |
ddc 530 bkl 52.56 Elsevier Perfusion imaging Elsevier Cerebral blood flow Elsevier 18F-FDG Elsevier Dual-phase PET Elsevier Early-phase PET Elsevier Alzheimer's disease Elsevier 15O-H2O Elsevier 18F-AV45 Elsevier R1 |
| format_facet |
Elektronische Aufsätze Aufsätze Elektronische Ressource |
| format_main_str_mv |
Text Zeitschrift/Artikel |
| carriertype_str_mv |
zu |
| author2_variant |
j v jv e n en r e d re red l w lw s c sc b c v bc bcv s e se s s ss s s ss |
| hierarchy_parent_title |
Multi-objective optimization of the solar absorptivity distribution inside a cavity solar receiver for solar power towers |
| hierarchy_parent_id |
ELV000066591 |
| dewey-tens |
530 - Physics |
| hierarchy_top_title |
Multi-objective optimization of the solar absorptivity distribution inside a cavity solar receiver for solar power towers |
| isfreeaccess_txt |
false |
| familylinks_str_mv |
(DE-627)ELV000066591 |
| title |
18F-FDG PET, the early phases and the delivery rate of 18F-AV45 PET as proxies of cerebral blood flow in Alzheimer's disease: Validation against 15O-H2O PET |
| ctrlnum |
(DE-627)ELV047979240 (ELSEVIER)S1552-5260(19)30151-7 |
| title_full |
18F-FDG PET, the early phases and the delivery rate of 18F-AV45 PET as proxies of cerebral blood flow in Alzheimer's disease: Validation against 15O-H2O PET |
| author_sort |
Ottoy, Julie |
| journal |
Multi-objective optimization of the solar absorptivity distribution inside a cavity solar receiver for solar power towers |
| journalStr |
Multi-objective optimization of the solar absorptivity distribution inside a cavity solar receiver for solar power towers |
| lang_code |
eng |
| isOA_bool |
false |
| dewey-hundreds |
500 - Science |
| recordtype |
marc |
| publishDateSort |
2019 |
| contenttype_str_mv |
zzz |
| container_start_page |
1172 |
| author_browse |
Ottoy, Julie |
| container_volume |
15 |
| physical |
11 |
| class |
530 VZ 52.56 bkl |
| format_se |
Elektronische Aufsätze |
| author-letter |
Ottoy, Julie |
| doi_str_mv |
10.1016/j.jalz.2019.05.010 |
| dewey-full |
530 |
| title_sort |
18f-fdg pet, the early phases and the delivery rate of 18f-av45 pet as proxies of cerebral blood flow in alzheimer's disease: validation against 15o-h2o pet |
| title_auth |
18F-FDG PET, the early phases and the delivery rate of 18F-AV45 PET as proxies of cerebral blood flow in Alzheimer's disease: Validation against 15O-H2O PET |
| abstract |
Dual-biomarker positron emission tomography (PET), providing complementary information on cerebral blood flow and amyloid-β deposition, is of clinical interest for Alzheimer's disease (AD). The purpose of this study was to validate the perfusion components of early-phase 18F-florbetapir (eAV45), the 18F-AV45 delivery rate (R1), and 18F-FDG against 15O-H2O PET and assess how they change with disease severity. |
| abstractGer |
Dual-biomarker positron emission tomography (PET), providing complementary information on cerebral blood flow and amyloid-β deposition, is of clinical interest for Alzheimer's disease (AD). The purpose of this study was to validate the perfusion components of early-phase 18F-florbetapir (eAV45), the 18F-AV45 delivery rate (R1), and 18F-FDG against 15O-H2O PET and assess how they change with disease severity. |
| abstract_unstemmed |
Dual-biomarker positron emission tomography (PET), providing complementary information on cerebral blood flow and amyloid-β deposition, is of clinical interest for Alzheimer's disease (AD). The purpose of this study was to validate the perfusion components of early-phase 18F-florbetapir (eAV45), the 18F-AV45 delivery rate (R1), and 18F-FDG against 15O-H2O PET and assess how they change with disease severity. |
| collection_details |
GBV_USEFLAG_U GBV_ELV SYSFLAG_U |
| container_issue |
9 |
| title_short |
18F-FDG PET, the early phases and the delivery rate of 18F-AV45 PET as proxies of cerebral blood flow in Alzheimer's disease: Validation against 15O-H2O PET |
| url |
https://doi.org/10.1016/j.jalz.2019.05.010 |
| remote_bool |
true |
| author2 |
Verhaeghe, Jeroen Niemantsverdriet, Ellis De Roeck, Ellen wyffels, Leonie Ceyssens, Sarah Van Broeckhoven, Christine Engelborghs, Sebastiaan Stroobants, Sigrid Staelens, Steven |
| author2Str |
Verhaeghe, Jeroen Niemantsverdriet, Ellis De Roeck, Ellen wyffels, Leonie Ceyssens, Sarah Van Broeckhoven, Christine Engelborghs, Sebastiaan Stroobants, Sigrid Staelens, Steven |
| ppnlink |
ELV000066591 |
| mediatype_str_mv |
z |
| isOA_txt |
false |
| hochschulschrift_bool |
false |
| author2_role |
oth oth oth oth oth oth oth oth oth |
| doi_str |
10.1016/j.jalz.2019.05.010 |
| up_date |
2024-07-06T17:38:09.823Z |
| _version_ |
1803852174930739200 |
| fullrecord_marcxml |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">ELV047979240</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230624142225.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">191023s2019 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1016/j.jalz.2019.05.010</subfield><subfield code="2">doi</subfield></datafield><datafield tag="028" ind1="5" ind2="2"><subfield code="a">/cbs_pica/cbs_olc/import_discovery/elsevier/einzuspielen/GBV00000000001216.pica</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)ELV047979240</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ELSEVIER)S1552-5260(19)30151-7</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">530</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">52.56</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Ottoy, Julie</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">18F-FDG PET, the early phases and the delivery rate of 18F-AV45 PET as proxies of cerebral blood flow in Alzheimer's disease: Validation against 15O-H2O PET</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2019</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">11</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zzz</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">z</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zu</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Dual-biomarker positron emission tomography (PET), providing complementary information on cerebral blood flow and amyloid-β deposition, is of clinical interest for Alzheimer's disease (AD). The purpose of this study was to validate the perfusion components of early-phase 18F-florbetapir (eAV45), the 18F-AV45 delivery rate (R1), and 18F-FDG against 15O-H2O PET and assess how they change with disease severity.</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Perfusion imaging</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Cerebral blood flow</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">18F-FDG</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Dual-phase PET</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Early-phase PET</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Alzheimer's disease</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">15O-H2O</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">18F-AV45</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">R1</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Verhaeghe, Jeroen</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Niemantsverdriet, Ellis</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">De Roeck, Ellen</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">wyffels, Leonie</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Ceyssens, Sarah</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Van Broeckhoven, Christine</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Engelborghs, Sebastiaan</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Stroobants, Sigrid</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Staelens, Steven</subfield><subfield code="4">oth</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="n">Elsevier</subfield><subfield code="a">Wang, Kun ELSEVIER</subfield><subfield code="t">Multi-objective optimization of the solar absorptivity distribution inside a cavity solar receiver for solar power towers</subfield><subfield code="d">2017</subfield><subfield code="d">the journal of the Alzheimer's Association</subfield><subfield code="g">Amsterdam [u.a.]</subfield><subfield code="w">(DE-627)ELV000066591</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:15</subfield><subfield code="g">year:2019</subfield><subfield code="g">number:9</subfield><subfield code="g">pages:1172-1182</subfield><subfield code="g">extent:11</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1016/j.jalz.2019.05.010</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ELV</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_U</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">52.56</subfield><subfield code="j">Regenerative Energieformen</subfield><subfield code="j">alternative Energieformen</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">15</subfield><subfield code="j">2019</subfield><subfield code="e">9</subfield><subfield code="h">1172-1182</subfield><subfield code="g">11</subfield></datafield></record></collection>
|
| score |
7.400098 |